Form 8-K - Current report:
SEC Accession No. 0001493152-25-010190
Filing Date
2025-03-13
Accepted
2025-03-13 16:05:18
Documents
13
Period of Report
2025-03-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40558
  Complete submission text file 0001493152-25-010190.txt   213535

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ibo-20250311.xsd EX-101.SCH 3033
3 XBRL LABEL FILE ibo-20250311_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ibo-20250311_pre.xml EX-101.PRE 24178
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3493
Mailing Address 1400 BROADFIELD BLVD. SUITE 130 HOUSTON TX 77084
Business Address 1400 BROADFIELD BLVD. SUITE 130 HOUSTON TX 77084 585 232 1500
IMPACT BIOMEDICAL INC. (Filer) CIK: 0001834105 (see all company filings)

EIN.: 853926944 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42212 | Film No.: 25735717
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)